Please contact us at email@example.com to get more information about how you can license the PEGylation technologies listed below.
We are pleased to offer several innovative PEG and PEGylation technologies for out-licensing as sole and non-exclusive licenses.
|JenKem Technology’s Out-Licensing Opportunities||US Patent Number||China Patent Number|
|Conjugate of polyethylene glycol and naloxone and pharmaceutical composition and use thereof||US8962647||ZL201210040133.2|
|Dasatinib and nonlinear configuration polyethylene glycol conjugate||US9566344||ZL201310241908.7|
|Stearic acid derivatives and oleic acid derivatives of multi-arm polyethylene glycol||US9890245||ZL201410717479.0|
|3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof||US9834530||ZL201410714845.7|
|Polyethylene glycol-cactus oligopeptide bonding rapamycin derivatives||US10098870||ZL201410715522.X|
|Conjugate of dezocine and polyethylene glycol||US10596268||ZL201611199383.5|
|Pegylated thioxanthone photoinitiator and photosensitive resin composition||US2020/0131147||ZL201810040940.1|
If you are interested in more details about JenKem Technology’s out-licensing opportunities, please contact us at firstname.lastname@example.org.
Founded in 2001 by experts in PEG synthesis and PEGylation, JenKem Technology specializes exclusively in the development and manufacturing of high quality polyethylene glycol (PEG) products and derivatives, and related custom synthesis and PEGylation services. JenKem Technology is ISO 9001 and ISO 13485 certified, and adheres to ICH Q7 guidelines for GMP manufacture. The production of JenKem® PEGs is back-integrated to in-house polymerization from ethylene oxide, enabling facile traceability for regulated customers. JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through large commercial scale.